SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [05/19/2026 07:22 PDT] SIGA Expected to Trade Down After Bearish Patterns Develop
• [04/17/2026 07:25 PDT] SIGA Expected to Trade Up After Bullish Patterns Develop